Lexaria Bioscience Corp. (LEXX)
1.23
+0.07
(+6.03%)
USD |
NASDAQ |
Dec 11, 16:00
1.24
+0.01
(+0.81%)
After-Hours: 20:00
Lexaria Bioscience Free Cash Flow: -10.55M for Aug. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Oncolytics Biotech, Inc. | -18.79M |
| Aurinia Pharmaceuticals, Inc. | 120.39M |
| Edesa Biotech, Inc. | -6.650M |
| Xenon Pharmaceuticals, Inc. | -253.05M |
| ProMIS Neurosciences, Inc. | -27.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.642M |
| Cash from Investing (Quarterly) | -0.1579M |
| Free Cash Flow Per Share (Quarterly) | -0.1358 |
| Free Cash Flow to Equity (Quarterly) | -2.650M |
| Free Cash Flow to Firm (Quarterly) | -2.657M |
| Free Cash Flow Yield | -47.63% |